Stem cell collection in patients with de novo multiple myeloma treated with the combination of bortezomib and dexamethasone before autologous stem cell transplantation according to IFM 2005-01 trial.

MLA

Moreau, P., et al. “Stem Cell Collection in Patients with de Novo Multiple Myeloma Treated with the Combination of Bortezomib and Dexamethasone before Autologous Stem Cell Transplantation According to IFM 2005-01 Trial.” Leukemia, vol. 24, no. 6, June 2010, pp. 1233–35. EBSCOhost, https://doi.org/10.1038/leu.2010.82.

APA

Moreau, P., Hulin, C., Marit, G., Caillot, D., Facon, T., Lenain, P., Berthou, C., Pégourié, B., Stoppa, A. M., Casassus, P., Michallet, M., Benboubker, L., Maisonneuve, H., Doyen, C., Leyvraz, S., Mathiot, C., Avet-Loiseau, H., Attal, M., & Harousseau, J. L. (2010). Stem cell collection in patients with de novo multiple myeloma treated with the combination of bortezomib and dexamethasone before autologous stem cell transplantation according to IFM 2005-01 trial. Leukemia, 24(6), 1233–1235. https://doi.org/10.1038/leu.2010.82

Chicago

Moreau, P, C Hulin, G Marit, D Caillot, T Facon, P Lenain, C Berthou, et al. 2010. “Stem Cell Collection in Patients with de Novo Multiple Myeloma Treated with the Combination of Bortezomib and Dexamethasone before Autologous Stem Cell Transplantation According to IFM 2005-01 Trial.” Leukemia 24 (6): 1233–35. doi:10.1038/leu.2010.82.